VitaNova Life Sciences (VNOV) Total Debt Growth (3y) (2020 - 2025)
VitaNova Life Sciences (VNOV) Total Debt Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | 28.31% |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 5.45% |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 35.92% |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 23.49% |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 29.96% |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | -3.80% |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | - |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 1.68% |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | 7.33% |
| 10 | VitaNova Life Sciences | - | - | 316,343.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2025 | 103.52% |
| Oct 31, 2024 | 119.52% |
| Apr 30, 2024 | -72.62% |
| Jan 31, 2024 | -33.29% |
| Oct 31, 2023 | -50.56% |
| Apr 30, 2023 | -46.27% |
| Jan 31, 2023 | -43.45% |
| Oct 31, 2022 | -47.12% |
| Jul 31, 2022 | -44.33% |
| Apr 30, 2022 | -37.78% |
| Jan 31, 2021 | 196.59% |
| Apr 30, 2020 | 164.67% |